Pharmaceutical - AstraZeneca

Filter

Current filters:

AstraZeneca

Popular Filters

226 to 250 of 310 results

STEMI guidelines now recommend AstraZeneca's ticagrelor as first-line treatment option

30-08-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) said yesterday that ticagrelor, its oral antiplatelet…

AstraZenecaBrilintaBriliqueCardio-vascularEffientEli LillyPharmaceuticalRegulation

AstraZeneca poaches Roche exec as CEO; Gets EU approval for Zinforo

28-08-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) this morning revealed that Pascal Soriot from rival Switzerland-based…

Antibiotics and Infectious diseasesAstraZenecaEuropeManagementPharmaceuticalRegulationRocheZinforo

AstraZeneca aligns with Regulus for microRNA therapeutics

16-08-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) and US biotech firm Regulus Therapeutics have signed…

AstraZenecaBiotechnologyCardio-vascularLicensingMetabolicsPharmaceuticalRegulus Therapeutics

AstraZeneca to get $250 million-plus from OTC Nexium deal with Pfizer

15-08-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) says it has entered into an agreement with Pfizer (NYSE:…

AstraZenecaFinancialGastro-intestinalsGlobalLicensingNexiumPfizerPharmaceutical

AstraZeneca to increase investments in Russian manufacturing plant

12-08-2012

AstraZeneca will increase the investments in the construction of its Russian drug manufacturing plant…

AstraZenecaEuropeFinancialPharmaceuticalProduction

AstraZeneca and Bristol-Myers complete diabetes alliance expansion; Lilly revises guidance

10-08-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) said yesterday that, following Bristol-Myers Squibb's…

AmylinAstraZenecaBiotechnologyBristol-Myers SquibbDiabetesEli LillyFinancialLicensingPharmaceutical

AstraZeneca/BTG abandon CytoFab for sepsis as it fails in Ph IIb

09-08-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) has decided to halt any further development of AZD9773…

Antibiotics and Infectious diseasesAstraZenecaBTGCytoFabLicensingPharmaceuticalResearch

Drug combo better for common type of metastatic breast cancer

02-08-2012

Postmenopausal women with the most common type of metastatic breast cancer now have a new treatment option…

ArimidexAstraZenecaFaslodexOncologyPharmaceuticalResearch

AstraZeneca sales and operating profit slump in 2nd-qrt 2012

26-07-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN this morning reported second-quarter 2012 financial results,…

AstraZenecaFinancialPharmaceutical

UK to implement child flu vaccines program

25-07-2012

UK Health Secretary Andrew Lansley yesterday accepted recommendations from UK immunization experts to…

Anti-viralsAstraZenecaFluenzHealthcarePharmaceuticalVaccines

Updated AHA/ACCF guidelines for unstable angina include newest blood-thinning drug

18-07-2012

Ticagrelor, Anglo-Swedish drug major AstraZeneca's (LSE: AZN) blood-thinning drug Brilique/Brilinta which…

AspirinAstraZenecaBrilintaBriliqueCardio-vascularClopidogrelNorth AmericaPharmaceuticalprasugrelRegulation

Ex-AstraZeneca CEO David Brennan to forego bonus

17-07-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) revealed yesterday the remuneration arrangements relating…

AstraZenecaFinancialManagementPharmaceutical

AstraZeneca buys Link Medicines neuroscience assets; enters Alzheimer's project

12-07-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) has acquired a portfolio of neuroscience assets from…

AstraZenecaLink MedicinesMergers & AcquisitionsNeurologicalPharmaceuticalResearch

Novo Nordisk and AstraZeneca among firms to invest in Russian pharma hub

11-07-2012

In Russia, the Kaluga government plans to establish a pharmaceutical manufacturing hub in the region…

AstraZenecaEuropeFinancialMarkets & MarketingMenariniNovo NordiskPharmaceuticalSTADA Arzneimittel

AstraZeneca completes sale of Aptium Oncology assets

09-07-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) says that it has completed the previously indicated sale…

Aptium OncologyAstraZenecaMergers & AcquisitionsOncologyPharmaceutical

New Zealand agrees to fund Iressa but amends Tarceva use

05-07-2012

New Zealand's pharmaceutical management agency PHARMAC has approved the proposal to fund AstraZeneca's…

Asia-PacificAstraZenecaIressaOncologyPharmaceuticalPricingRegulationRocheTarceva

Germany's IQWiG finds no proof of added benefit for AstraZeneca's Caprelsa in thyroid cancer

05-07-2012

The German Institute for Quality and Efficiency in Health Care (IQWiG) has now examined the added benefit…

AstraZenecaCaprelsaEuropeOncologyPharmaceuticalPricingRegulation

Slow-down of European bipolar therapy market set for short-term slowdown

04-07-2012

Patent expiry of key blockbuster atypical antipsychotic drugs is likely to cause a decline in growth…

AstraZenecaEuropeGenericsMarkets & MarketingNeurologicalPatentsPharmaceuticalPricingSeroquel

Merck & Co to continue posting sales and profits under AstraZeneca partnership

28-06-2012

US drug giant Merck & Co (NYSE: MRK) and Anglo-Swedish major AstraZeneca have amended the option agreement…

AstraZenecaFinancialGastro-intestinalsLicensingMerck & CoNexiumPharmaceuticalPrilosec

226 to 250 of 310 results

Parexel

Parexel

Back to top